[DOI] [PubMed] [Google Scholar] 593
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided, or will provide, a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
Section 503A allows pharmacies to compound medications using bulk drug substances only if specific requirements are met
Access this chapter Similar content being viewed by others References Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG
For researchers and individuals serious about optimizing their peptide and supplement protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Temperature effects resolve within days
